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Material and Methods: Three cell lines were depleted from 
their mtDNA by ethidium bromide. BEAS-2B immortalized 
bronchial epithelial, A549 lung adenocarcinoma and 143B 
osteosarcoma cell lines and their mtDNA depleted 
counterparts (ρ0) were metabolically characterized using the 
XF96 Seahorse. Changes in radiosensitivity were assessed by 
clonogenic survival (0, 2, 4, 6 and 8Gy). ROS production (by 
dihydrorhodamine FACS analysis), ATP (Cell-TiterGlo 
Luminescent cell viability test) and glutathione levels (in cell 
lysate) as well as γH2AX immunostainings were assessed 24 
hours post irradiation. 
 
Results: mtDNA depletion resulted in a significant (p<0.05) 
decreased proliferation (64 ± 7%) for all cell lines. Compared 
to their respective controls, increased clonogenic survival 
was observed for the BEAS-2B ρ0 cells (p=0.004) after 
irradiation, while both tumor ρ0 lines were more radiation 
sensitive (p=0.013), mainly at higher irradiation doses. ROS 
formation at baseline (0Gy) was similar (p=0.878) for BEAS-2B 
parental and ρ0, while reduced for A549 and 143B ρ0 
(p=0.021) cells, compared to their parental counterparts. 24 
hours after irradiation ROS levels were significantly (p<0.05) 
increased for all parental cell lines, while levels for the ρ0 
cells remained equal. Glutathione levels were lower for the 
A549 and 143B ρ0 cell lines compared to the parental lines 
under any experimental condition but no changes were found 
for the BEAS-2B cells. In agreement, increased residual DNA 
damage was observed upon mtDNA depletion for A549 and 
143B cells. Depletion of mtDNA reduced cellular ATP levels 
only for the BEAS-2B cell line (p=0.046), but not for the A549 
and 143B cell lines in high glucose culture medium. 
 
Conclusion: The observed differences in dependence on 
mitochondrial function for radioresponsiveness appear to be 
associated with the balance in ROS levels and the antioxidant 
status of the cells. Currently, the levels of MnSOD and GPX1 
and the effect of ROS scavenging on radiotherapy response 
are investigated in our lab. 
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Purpose or Objective: We have previously shown that 
lysosome-associated membrane protein-3 (LAMP3), a protein 
involved in the unfolded protein response pathway, is 
involved in resistance to both endocrine (tamoxifen) 
treatment and radiotherapy in breast cancer patients. We 
have created subclones of the MCF7 breast cancer cell line 
that are resistant to either treatment. In these subclones, we 
investigated common mechanisms between tamoxifen- and 
radioresistance, and the possible role of LAMP3 therein. 
Material and Methods: The estrogen receptor positive breast 
cancer cell line MCF7 was grown to tamoxifen resistance 
(MCF7TAM) by culturing with gradually increasing 
concentrations of 4-OH-tamoxifen up to 10 μM. Additionally, 
MCF7 cells were exposed to multiple fractions of 2 or 4 Gy 
irradiation, adding up to a total dose of at least 50 Gy 
(MCF7RT). Changes in expression profiles in MCF7TAM and 
MCF7RT cells compared to parental MCF7 cells were 
investigated by RNA sequencing. Pathway analysis software 
was used to find pathways involved in tamoxifen- and 
radioresistance. QPCR was used to confirm the RNA 
sequencing data, and to investigate the changes in genes of 
interest after tamoxifen treatment and irradiation.The role 
of LAMP3 in these treatment resistance pathways is being 
elucidated by performing LAMP3 gene silencing by siRNA and 
CRISPR-Cas mediated gene knockout.  
 
Results: The MCF7TAM cells were completely resistant to 
treatment with 10 μM 4-OH-tamoxifen. Remarkably, these 
cells had also become resistant to irradiation, with a 
surviving fraction at 4 Gy (SF4) of 19.7%, compared to 8.3% 
for the parental MCF7 cells. MCF7RT cells were less sensitive 
to irradiation with a SF4 of 9.6% compared to 3.9% for the 
parental cells. RNA sequencing of MCF7TAM and MCF7RT cells 
revealed an increase of genes involved in the antiviral 
response, including classic interferon response genes such as 
IFI6 (shown in figure, left), IFI27, STAT1, OAS1 and DDX60. 
These genes were increased in parental cells following 4 Gy 
irradiation (figure, right) or tamoxifen treatment as well. 
 
 
Conclusion: MCF7 cells resistant to tamoxifen treatment are 
also less sensitive to irradiation,suggesting a common 
mechanism in the resistance to these diverse types of 
treatment. Using an unbiased approach, we here show that 
interferon response genes are increased in both MCF7TAM 
and MCF7RT cells. Interestingly, others have shown LAMP3 to 
be a regulator for this pathway. We are currently 
investigating the role of LAMP3 in our treatment resistant 
breast cancer clones. 
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Purpose or Objective: The brain tumor glioblastoma 
multiforme (GBM) is highly malignant with a very short OS 
due to rapid recurrences adjacent to the primary tumor. 
Even radio-chemotherapy extends the survival only for a few 
months. In this project we tested whether or not the 
Slit2/Robo1 axon guidance system might be involved in the 
migration of metastatic GBM cells and whether irradiation 
with photons might modify this putative effect. 
 
Material and Methods: The experiments were performed 
with 2 human GBM cell lines (U87 and U373) and in parallel 
after irradiation with 0.5, 2, or 8 Gy photons. The 
motility/migration of the cells was analyzed by time-laps 
videography. Travelling cells were tracked and the 
parameters accumulated distance and Euclidean distance 
were determined. The expression of Slit2, Robo1, and FAK 
(focal adhesion kinase) was tested by Western blot and qRT-
PCR. In addition, the cells were transfected either with a 
Robo1 expression-vector or with a siRNA construct and 
analyzed similarly. 
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Results: Irradiation with low doses enhanced the motility of 
the cells. Slit2 as well as Robo1 was extremely low expressed 
in the cell line with higher motility (U87). Irradiation reduced 
the expression even more. On the other hand, a stable 
overexpression of Robo1 decreased significantly the migration 
of the cells and suppressed the increase in motility observed 
after irradiation. In contrast, the siRNA mediated knockdown 
of Robo1 increased the migratory potential of the cells. The 
analysis of FAK, a key player in cellular migration, revealed a 
decreased expression in Robo1-overexpressing cells. 
 
Conclusion: Our data indicate a role for Robo1 in the 
migration of malignant GBM cells. The expression of Robo1 
reduced the migration of these cells and was also able to 
impede the increase in motility observed after irradiation 
with photons. 
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Purpose or Objective: Proton minibeam radiotherapy aims to 
minimize normal tissue damage in the entrance channel 
while keeping tumor control through a homogeneous tumor 
dose due to channel widening with increasing track length. 
Side effects of proton minibeam irradiation were examined in 
an in-vivo mouse model to account for immune system, 
vasculature and higher complexity. Here, we report on our 
comparative study of minibeam and broad beam irradiation in 
the ear of Balb/c mice, to prove this hypothesis of reduced 
adverse effects in normal tissue. 
 
Material and Methods: At the ion microprobe SNAKE, 20 MeV 
protons were administered to the right ear of 2-3 months old, 
female Balb/c mice, using an average dose of 60 Gy in a field 
of 7.2 x 7.2 mm2 in the central part of the ear, in two 
irradiation modes, homogeneous and minibeams. The 4 x 4 
minibeams of 180 x 180 µm2 size were set in a distance of 1.8 
mm, resulting in a dose of 6000 Gy in the channels, but with 
negligible dose in between. Inflammatory response, i.e. ear 
swelling and skin reactions were monitored for 90 days 
following irradiation, as well as genetic damage and release 
of inflammatory proteins. 
 
Results: No ear swelling or other skin reaction was detected 
after the minibeam irradiations, while significant ear swelling 
(up to 4-fold), erythema and desquamation (crust formation) 
developed in homogeneously irradiated ears 3-4 weeks after 
irradiation. Loss of hair follicles was only detected in the 
homogeneously irradiated fields after 4-5 weeks. 
 
Conclusion: Our results prove that proton minibeam 
radiotherapy leads to reduced side effects compared to 
conventional broad beam irradiation and could become an 
option in clinical proton and/or heavy ion therapy.  
Supported by the DFG Cluster of Excellence: Munich-Centre 
for Advanced Photonics. 
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Purpose or Objective: Metastasis is an important cause of 
mortality in cancer patients and evidence shows that 
irradiation could actually increase the formation of 
metastasizing cells. An important pathway implicated in the 
process of metastasis is the Hedgehog (Hh) signaling 
pathway. Recent studies demonstrated that activation of this 
pathway can lead to radioresistance. So far, the impact of 
high-LET radiation on the Hh pathway is still unknown. In the 
present study the impact of different radiation qualities (e.g. 
X-rays and carbon ions) on Hh gene expression was 
investigated in prostate cancer cells (PC3) and 
medulloblastoma cells (DAOY). 
 
Material and Methods: In vitro models used for prostate 
cancer and medulloblastoma were PC3 and DAOY, 
respectively. Colony survival assays were performed to 
analyze the effect of radiation on cell survival. The impact of 
radiation on the expression of the different Hh signaling 
pathway components (SHH, PTCH, SMO, GLI1, GLI2, GLI3 and 
SUFU) was investigated by means of RT-qPCR. Experiments 
with X-rays were performed at SCK•CEN (Mol, Belgium) 
whereas carbon ion irradiation (LET = 33.7 KeV/µm) 
experiments were performed at the Grand Accélérateur 
National d’Ions Lourds (GANIL) (Caen, France).  
 
Results: Colony survival assays showed that DAOY cells were 
more radioresistant than PC3 cells (respectively D10=5.3 Gy 
and D10=4.2 Gy). Evaluation of the Hh signaling pathway 
showed that basal gene expression is present in both PC3 and 
DAOY, although very low. However, basal gene expression of 
the Hh components differed between both cell lines. 
Moreover, the more radioresistant cell line DAOY had higher 
expression levels of Gli1 compared to the PC3 cells. 
Preliminary RT-qPCR results show that different radiation 
qualities induce different changes in the expression of the Hh 
signaling components. 
 
Conclusion: In conclusion, radiation exposure can induce 
changes in the Hh pathway. Future experiments will address 
whether modulation of the Hh pathway also affects the radio-
responsiveness of cancer cells. 
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Purpose or Objective: This retrospective study aimed to 
compare and determine the potential dosimetric benefits of 
intensity-modulated radiotherapy (IMRT) treatment plans 
with (FF) and without flattening filter (FFF) as well as to 
explore the dosimetric differences in 6MV FFF and 10MV FFF 
plans for non-small-cell lung carcinoma (NSCLC). 
 
Material and Methods: Ten cases of CT data were selected 
from NSCLC patients. 4 sets of 5-field-IMRT plans were 
computed with FFF beams (X6FFF, X10FFF) and flattened 
beams (X6FF, X10FF) with the prescription of total 60Gy in 30 
fractions. Planning constraints were based on the Radiation 
